Response to Letter to the Editor entitled “Methodological considerations in assessing the clinical impact of TP53 classifications in advanced NSCLC”

Deborah Di-Xin Zhou, Chee Khoon Lee

Open source

DOI
10.1016/j.lungcan.2026.109303
Published
2026-04
Container
Lung Cancer
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lungcan.2026.109303,
  title = {Response to Letter to the Editor entitled “Methodological considerations in assessing the clinical impact of TP53 classifications in advanced NSCLC”},
  author = {Deborah Di-Xin Zhou and Chee Khoon Lee},
  year = {2026},
  journal = {Lung Cancer},
  doi = {10.1016/j.lungcan.2026.109303},
  url = {https://doi.org/10.1016/j.lungcan.2026.109303}
}

RIS

TY  - JOUR
TI  - Response to Letter to the Editor entitled “Methodological considerations in assessing the clinical impact of TP53 classifications in advanced NSCLC”
AU  - Deborah Di-Xin Zhou
AU  - Chee Khoon Lee
PY  - 2026
JO  - Lung Cancer
DO  - 10.1016/j.lungcan.2026.109303
UR  - https://doi.org/10.1016/j.lungcan.2026.109303
ER  - 

APA

Zhou, D. D., & Lee, C. K. (2026). Response to Letter to the Editor entitled “Methodological considerations in assessing the clinical impact of TP53 classifications in advanced NSCLC”. Lung Cancer. https://doi.org/10.1016/j.lungcan.2026.109303

Source records